Chicago Partners Investment »

Cue Biopharma shares owned by Chicago Partners Investment

Quarter-by-quarter ownership of Cue Biopharma (CUE) shares owned by Chicago Partners Investment from 13F filings

Historical chart of Chicago Partners Investment investment in Cue Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Cue Biopharma held by Chicago Partners Investment consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cue Biopharma by Chicago Partners Investment

Quarter filed Position value Share count Share price at filing
2025-09-30 $64k 86k 0.74
2025-06-30 $79k 88k 0.89
2025-03-31 $69k 90k 0.77

More positions owned by Chicago Partners Investment

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Mid Cap Etf (VO)
NVIDIA Corporation (NVDA)
Dimensional Etf Trust Us Equity Market (DFUS)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Apple (AAPL)
Vanguard Index Fds Growth Etf (VUG)
Microsoft Corporation (MSFT)
Enterprise Products Partners (EPD)
Ishares Tr Core S&p Mcp Etf (IJH)
Energy Transfer Com Ut Ltd Ptn (ET)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Innovator Etfs Trust Quity Managd Flr (SFLR)
Dimensional Etf Trust Us Small Cap Etf (DFAS)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)

View all positions for Chicago Partners Investment

Top funds holding Cue Biopharma

Bleichroeder
Catalytic Wealth RIA
Vanguard Group
Geode Capital Management
Boothbay Fund Management
Robertson Stephens Wealth Management
BlackRock
Advisory Research
Renaissance Technologies
UBS Group
Stifel Financial
State Street Corporation
Susquehanna International
Angeles Wealth Management
Northern Trust

View all funds holding Cue Biopharma